Eight hub genes, namely, TXN, ANXA2, TPM4, LOXL2, TPRN, ADCY6, TUBA1C, and CMIP, were identified and validated as associated with the progression and poor prognosis of breast cancer. Here, LOXL2 is linked to breast carcinoma.